More than 25 years after Jesse Gelsinger’s death during a gene therapy trial, the ethical questions his case raised remain relevant. What have we learned about risk, informed consent & research oversight, and what still needs to change?
Join the conversation on 10/2 @ 12pm ET
🔗: evt.to/gmaioguhw
